Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-FAPI-46 PET/CT in Early Detection of Lymph Node Metastasis in HNSCC
NCT06794372Phase 2Recruiting
- Start
- Jun 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga FAPI-46 in head and neck squamous cell carcinoma (HNSCC). Started Jun 2025; status: recruiting.
02
Drugs
68Ga FAPI-46
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT06794372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794372.